News

A recent study published in Frontiers in Neurology reveals intriguing insights into the relationship between vitiligo and Parkinson's disease (PD)....

The recent heat wave across the United States has brought scorching temperatures, posing challenges for those with sensitive skin conditions...

Dermatologists in New Zealand have highlighted a significant gap in the treatment of eczema, with many patients unable to access...

After a decade of dedicated research, the "Skin Twins" are introducing an exclusive survey aimed at enhancing understanding of skin...

A recent study published in Skin Health and Disease reveals that just over a quarter of dermatologists in Hungary (25.5%)...

Experts are advocating for increased assistance for New Zealanders aged 65 and older, who face heightened risks associated with shingles,...

A recent survey has shed light on the profound impact of eczema on New Zealanders, revealing a relentless pursuit for...

In the midst of Gaza's ongoing humanitarian crisis, children are facing a new threat: rampant skin diseases. Wafaa Elwan, a...

The US Food and Drug Administration (FDA) has approved Pyzchiva (ustekinumab-ttwe), a biosimilar developed by Samsung Bioepis Co., Ltd., for...

Almirall's Ilumetri (tildrakizumab) has shown promising results in restoring the well-being of patients with moderate to severe plaque psoriasis to...